Mainz Biomed (MYNZ) Issues H1 2022 Corporate Update

Mainz Biomed N.V. (NASDAQ: MYNZ) is pleased to host a webcast on July 12, 2022 at 4:00pm ET to provide an update on the Company’s progress for the first half of 2022, and to outline the plan for the balance of the fiscal year.

The webcast will offer the investment community a comprehensive briefing by Mainz’s executive management team on the Company’s flagship product ColoAlert, a highly efficacious, and easy-to-use detection test for colorectal cancer (CRC) which is being commercialized internationally through a differentiated business model of partnering with third-party laboratories for test kit processing versus the traditional methodology of operating a single facility. The presentation will also include an update on the status of ColoAlert’s U.S. regulatory approval pathway, the ongoing R&D efforts to potentially upgrade ColoAlert’s technical profile to achieve “gold standard” status for CRC at-home testing, an overview of additional products in development, and the Company’s go-forward strategy to facilitate growth.

“Given the progress achieved over the past six months across all aspects of the company, the management and Board thought it was appropriate to host this interactive forum to provide an overall update on progress, especially in light of our recent transition to the public sector this past November,” commented Guido Baechler, Chief Executive Officer of Mainz Biomed. “We look forward to providing a detailed presentation covering ColoAlert’s commercial execution and clinical development status along with commentary on the balance of the product development pipeline, and our overall strategy to become a leading oncology focused diagnostic company.”

Mainz Biomed - Mid-Year UpdateConference ID: 13730909Date and Time: Tuesday July 12, 2022, 4:00 PM ET

To access the webcast, please register HERE

For dial in access, please use the following:Toll Free: 1-877-269-7751Toll/International: 1-201-389-0908

The Mainz mid-year update will be made available for replay for 14 days after the event.

The webcast replay can be accessed HEREToll Free: 1-844-512-2921Toll/International: 1-412-317-6671Replay Pin Number: 13730909Replay Start: Tuesday July 12, 2022, 7:00 PM ETReplay Expiry: Tuesday July 26, 2022, 11:59 PM ET

You May Also Be Interested In

• ArcelorMittal Q2 2026 analyst consensus: $2.04B EBITDA expected
• Elme Communities cuts liquidating distribution estimate after Riverside deal
• BayCom director resigns with no disagreement cited